Suscribirse

IRRITABLE BOWEL SYNDROME - 06/09/11

Doi : 10.1016/S0025-7125(05)70285-6 
Robin D. Rothstein, MD *

Resumen

Irritable bowel syndrome (IBS) is the most common functional disorder of the gastrointestinal tract. As a result of the lack of specific diagnostic testing and absence of circumscribed biologic markers of disease, the diagnosis is based on a constellation of symptoms. In an attempt to standardize the definition of disease, an international consensus group formalized clinical parameters based on data from Manning et al40 for a symptom-based diagnosis. In reference to the location of the meeting, these criterion have been termed the Rome criteria and subsequently have been refined further (see the accompanying box).59 At present, because of incomplete understanding of the pathophysiology of IBS, patient subsets are defined by their predominant symptom (Figure 1).


Rome Criteria of Irritable Bowel Syndrome

Continuous or recurrent symptoms of:
Abdominal pain or discomfort that is relieved with defecation
Abdominal pain or discomfort that is associated with a change in frequency or stool
Abdominal pain or discomfort that is associated with a change in consistency of stool
Two or more of the following, for at least a quarter of occasions or days:
Altered stool frequency (>3 bowel movements per day or <3 bowel movements per week)
Altered stool form (lumpy/hard or loose/watery stool)
Passage of mucus
Bloating or feeling of abdominal distension

Symptoms of IBS have afflicted humans since antiquity. Maimonides advised that humans should strive to have their intestines relaxed all the days of their lives. IBS is a common disorder affecting approximately 15% of the population.1 One third seek medical attention from their primary physician, and 10% to 15% are referred to a gastroenterologist.47 Based on the large portion of the population affected, the societal costs of the disease are immense. Physician visits total approximately 3.5 million a year, and medications are prescribed for most patients, averaging 2.2 million prescriptions a year.19, 23 In a comparative study in 1992 dollars, office-based costs averaged $742 per IBS patient compared with $429 for nonpatients.57 Pharmacologic costs are significantly greater in IBS patients.14 Patients with IBS have a greater likelihood of suffering other medical and gastrointestinal problems.43 For example, functional dyspepsia occurs in more than one third of IBS sufferers.56 Patients with IBS are more likely to undergo surgery, including hysterectomies and appendectomies, and are more apt to have had multiple operations.38 Evaluation and treatment of associated disorders and the greater tendency for additional surgery inflate health care costs further.

Indirect costs are more difficult to calculate but appear substantial. In one study, absenteeism over 1 year averaged 13.4 days for patients with IBS compared with 4.0 days for controls. The diagnosis and treatment of IBS and its associated problems account for billions of health care dollars.

El texto completo de este artículo está disponible en PDF.

Esquema


 Address reprint requests to Robin D. Rothstein, MD, Division of Gastroenterology, Pennsylvania Hospital, University of Pennsylvania Health System, Spruce Building, 9th Floor, 8th and Spruce Streets, Philadelphia, PA 19107


© 2000  W. B. Saunders Company. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 84 - N° 5

P. 1247-1257 - septembre 2000 Regresar al número
Artículo precedente Artículo precedente
  • CONSTIPATION
  • Arnold Wald
| Artículo siguiente Artículo siguiente
  • DIARRHEA
  • Lawrence R. Schiller

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.